Study maps enrofloxacin, doxycycline depletion in quail eggs

A new Veterinary Sciences paper tackles a practical gap in avian pharmacology: how long enrofloxacin and doxycycline remain in eggs after Chinese White-feathered quail are medicated through drinking water. The study's stated goal was to define depletion kinetics and develop suitable withdrawal times, using dose levels tied to the Chinese Veterinary Pharmacopoeia. That matters because quail are a food-producing species, but most published egg residue data and withdrawal discussions still center on laying hens rather than quail. (onlinelibrary.wiley.com)

The background is familiar to anyone who works in poultry medicine. Eggs are a difficult matrix for residue control because they form over multiple days, and drug movement into yolk, albumen, and even eggshell can follow different timelines. Reviews of veterinary drug pharmacokinetics in laying birds have long noted that residues can continue appearing in eggs after treatment stops, and more recent work has shown transfer of compounds such as enrofloxacin into multiple egg components, including eggshell. (onlinelibrary.wiley.com)

That broader context is one reason species-specific depletion work matters. Prior studies have shown doxycycline withdrawal times in Japanese quail tissue can vary by jurisdictional MRL framework, and work in laying hens has documented measurable egg residues for both doxycycline and enrofloxacin after oral or drinking-water administration. Older hen studies suggested roughly five- to six-day withdrawal periods for some fluoroquinolone regimens, while doxycycline residue patterns in eggs have shown a shift over time from higher egg-white concentrations early to relatively greater yolk persistence later in depletion. (pubmed.ncbi.nlm.nih.gov)

The new quail study appears especially relevant because it models a real-world administration route: drinking water. That's important operationally, since water medication is common in flock treatment, and residue outcomes can be influenced by dose, duration, species, production stage, and how consistently birds consume medicated water. The paper's design, with high and low dose groups and daily egg monitoring, should help veterinarians and residue specialists interpret whether current withdrawal assumptions for chickens are conservative enough, or not, when applied to quail eggs. (pmc.ncbi.nlm.nih.gov)

Outside the study itself, surveillance and regulatory context underscore why the findings matter. A 2022 Veterinary Sciences survey of poultry eggs in Shandong, China detected multiple antibiotic residues, including enrofloxacin and doxycycline, and noted that enrofloxacin was found in eggs across multiple years of sampling. Chinese food safety standards have set MRLs for some veterinary drugs in poultry eggs, and official technical guidance has separately warned about residue problems in eggs from laying birds. Taken together, that suggests residue depletion studies like this one are not just academic; they're part of a larger push to tighten prescribing, withdrawal compliance, and monitoring in egg-producing flocks. (mdpi.com)

I didn't find substantial independent expert commentary tied specifically to this paper, which isn't unusual for a niche residue-depletion study. Still, the wider literature is consistent on the main point: antimicrobial residues in eggs are a public health and market-access issue, and they also connect to antimicrobial resistance concerns. Reviews and analytical studies repeatedly frame enrofloxacin and doxycycline as compounds that warrant close residue monitoring in eggs and egg products. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the main takeaway is that quail need their own evidence base. If you're advising on treatment protocols in laying birds, especially minor species, extrapolating from chicken labels or older hen studies can create risk on both sides: unnecessarily long withholding that disrupts production, or too-short withdrawal advice that leaves violative residues in eggs. This is especially sensitive for fluoroquinolones such as enrofloxacin, given their regulatory scrutiny and stewardship implications. FARAD materials in the U.S. have also emphasized the complexity of egg residue recommendations and note that enrofloxacin is prohibited from extralabel use in U.S. food animals. (vet.osu.edu)

What to watch: The next step is whether the paper's withdrawal estimates are validated in additional quail populations, compared against market-specific residue thresholds, and translated into practical guidance for veterinarians, integrators, and residue control programs. If more quail-focused data emerge, they could help refine prescribing decisions, improve residue avoidance plans, and support more defensible advice to producers and pet parents who also keep small laying flocks. (vet.osu.edu)